Although VAP-1/CD68 and VAP-1/iNOS also exhibited their diagnostic properties for overall survival, they did not exhibit the same degree of diagnostic accuracy in gliomas as that of VAP-1/CD163 (VAP-1/CD68, AUC = 0.7300; VAP-1/iNOS, AUC = 0.5535) (Figure 4). This evidence concerns the gene CD163 and central nervous system cancer.